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Background: There is growing evidence about the importance of epicardial adiposity on cardiometabolic risk.
However, the relation of location-specific epicardial adipose tissue (EAT) thickness to coronary atherosclerotic
burden is still unclear.
Methods: This meta-analysis was used to study the relations between location-specific EAT thickness and obstructive
coronary artery disease (CAD). A systemic literature search to identify eligible studies that met the inclusion criteria from
the beginning until January 2014 was made. We conducted the meta-analysis of all included 10 published studies.
Pre-specified subgroup analyses were performed according to ethnicity, body mass index, diagnostic tools for CAD,
and measurement tool if presence of high heterogeneity between studies. Potential publication bias was also assessed.
Results: We identified ten observed studies with a total of 1625 subjects for planned comparison. With regard to the
association between obstructive CAD and location-specific EAT thickness at the right ventricular free wall, caution is
warranted. The pooled estimate showed that location-specific EAT thickness at the right ventricular free wall
was significantly higher in the CAD group than non-CAD group (standardized mean difference (SMD): 0.70 mm,
95% CI: 0.26-1.13, P = 0.002), although heterogeneity was high (I2 = 93%). It should be clear that only the result of
echocardiography-based studies showed a significant association (SMD: 0.98 mm, 95% CI: 0.43-1.53, P = 0.0005), and
the result of all included CT-based studies showed a non-significant association (SMD: 0.06 mm, 95% CI: -0.12-0.25,
P = 0.50). In the subgroup analysis, the “diagnostic tools for CAD” or “measurement tool of EAT thickness” are
potential major sources of heterogeneity between studies. With regard to location-specific EAT thickness at the
left atrioventricular (AV) groove, it was significantly higher in the CAD group than non-CAD group (SMD: 0.74 mm,
95% CI: 0.55-0.92, P <0.00001; I2 = 0%).
Conclusion: Our meta-analysis suggests that significantly elevated location-specific EAT thickness at the left AV
groove is associated with obstructive CAD. Based on the current evidence, the location-specific EAT thickness
at the left AV groove appears to be a good predictor in obstructive CAD, especially in Asian populations. Furthermore
well-designed studies are warranted because of the current limited number of studies.
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Excessive epicardial adipose tissue (EAT) accumulation
within the pericardial sac has been suggested to play an
important role in the development of coronary artery
atherosclerosis through potential paracrine or endocrine
mechanism by exerting inflammatory mediators such as
TNF-alpha, IL-6, adipocytokines, and leptin [1-5]. Several
previous studies have found that CT-measured EAT
volume played an important causal role in coronary
atherosclerotic burden or coronary artery disease [6-8].
There is increasing attention on the location-specific
EAT thickness as a potential predictor in cardiometa-
bolic disease because of uneven regional distribution of
EAT around the heart, especially mostly located in the
atrioventricular (AV) groove and interventricular (IV)
groove [9-11]. Echocardiographic EAT measurement is a
non-invasive and simple way to measure location-
specific EAT at the right ventricular free wall clinically
[12-17]. Alternatively, CT (computed tomography) or
MRI (magnetic resonance imaging) can also provide the
simple but precise 2D measurement in the thickness of
EAT in all cardiac segments [11,18,19]. Current evidence
about the association between location-specific EAT
thickness at the right ventricular free wall and coronary
artery disease (CAD) is still controversial. Several studies
using echocardiography have demonstrated a significant
relationship between CAD and location-specific EAT thick-
ness measured at right ventricular free wall [13,14,16,17],
while some studies using echocardiography or CT failed to
observe a significant association [11,12,19,20]. Recent evi-
dence has suggested that there is increasing attention on
location-specific EAT thickness at the left AV groove as a
potentially new biomarker associated with cardiometabolic
risks by using 2D CT or MR measurement [11,19,21,22].
In this study, we conducted a meta-analysis to study the
relationship between location-specific EAT thickness and
obstructive CAD, which may serve as a reliable predictor
and improve CAD risk stratification in the future.
Methods
This meta-analysis was conducted according to the
Meta-analysis Of Observational Studies in Epidemiology
(MOOSE) statement [23].
Search strategy
We searched the Pubmed, Ovid Medline, Ovid Embase
and Cochrane databases for relevant articles. Reviews
were independently performed by two authors using the
following search terms: “epicardial adipose tissue”, “epi-
cardial fat”, “subepicardial adipose tissue”, “subepicardial
fat”, “coronary artery disease [Mesh]”, “atherosclerosis
[Mesh]”, and “cardiovascular disease [Mesh]”, from the
beginning of publication until January 2014. No language
restrictions were applied. The pre-specified inclusioncriteria were as follows: (a) observational studies to in-
vestigate the relationship between location-specific EAT
thickness and CAD measured by echocardiography, CT
or MRI-based quantitative measurements; (b) subjects
with suspicion of CAD or at high risk of CAD clinically,
and then subsequently divided into CAD and non-CAD
groups assessed by coronary angiography, coronary CT
angiography and coronary MR angiography. CAD group
was defined as luminal stenosis ≥ 50% in one or more
coronary arteries; and (c) for each study, the mean differ-
ence, standard deviation (SD) and sample size of subjects of
CAD and non-CAD groups were reported in the literature.
References within studies that met the inclusion criteria
were reviewed for any possible missing relevant articles.
Studies were excluded if any of the inclusion criteria were
not met. All 10 published studies that met these inclusion
criteria were considered eligible for further meta-analysis.Data extraction and quality assessment
Data were abstracted and quality of studies was assessed
independently by two reviewers (F.Z.W. and M.T.W.).
Disagreement on specific studies between the two re-
viewers was resolved by consensus. Data were extracted
from each study including the sample size and mean
difference ± SD in location-specific EAT thickness in
both CAD and non-CAD groups (regrouping and
calculating the mean difference and mixed SD in the
study of Eroglu et al. [14]). Methodological study qual-
ity was assessed using the Strengthening of Reporting
of Observational Studies in Epidemiology (STROBE)
checklist of 22 items [24].Data analysis
All statistical analyses were performed using the Com-
prehensive Meta-Analysis version 2 (Biostat, Englewood,
New Jersey) and the Review Manager 5.0 software, available
through the Cochrane Collaboration. Both fixed- and
random-effects models were used for analysis of the stan-
dardized mean difference (SMD) in the CAD and non-
CAD group. Heterogeneity was assessed and quantified
using Cochran’s Q statistic and the I2 statistic [25]. If I2 was
below 30%, fixed effects were chosen; if I2 was equal to or
greater than 30%, then random effects were applied [26].
Before the analysis, we formed a prior hypothesis that if
heterogeneity existed in the studies, the source could be
due to: (1) diagnostic tool for CAD (coronary angiography
vs. coronary CT angiography); (2) ethnicity (Asian vs. non-
Asian); (3) measurement tool of EAT (echocardiography vs.
CT); and (4) body mass index (BMI). We also performed
subgroup and univariate meta-regression analyses to inves-
tigate potential sources of variability. Publication bias was
assessed if available by using Egger’s test to examine the
likely presence of publication bias.
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Study identification and selection
Overall, 312 articles were initially identified according to
the broad criteria. After the initial screening of the title
and abstract, 21 potentially relevant articles were re-
trieved for detailed review of their full text. Many studies
that investigated the association between epicardial fat
volume and CAD were excluded in this step.
In all these relevant studies, 11 studies were excluded
after the detail review of their full text. Of these 11 stud-
ies, five studies were excluded because they did not re-
port the detailed data for the meta-analysis [27-31]; two
studies were excluded because of an investigation of the
relationship between the EAT volume or area with CAD
[32,33]; two studies were excluded because the study
subjects were not well-defined or did not meet the
criteria [15,34]; and the remaining two were letters and
experimental studies [5,35]. The remaining 10 observa-
tional studies were eligible for the meta-analysis
[11-14,16,17,19-21,36]. The flowchart of the search
and selection of studies in this meta-analysis is illus-
trated in Figure 1. Overall, these studies included 1625
patients (924 subjects with CAD, and 701 subjects
without CAD).
Table 1 summarize the characteristics of the nine
observational studies investigating the association between
location-specific EAT thickness at the right ventricular
free wall and obstructive CAD. Table 2 summarizes
the characteristics of the three observational studies
investigating the association between location-specific
EAT thickness at the left AV groove and obstructive
CAD.Figure 1 Flowchart of study selection process to determine the stu
adipose tissue.Location-specific EAT thickness at the right ventricular
free wall and obstructive CAD
With regard to the association between the location-
specific EAT thickness at the right ventricular free wall
and obstructive CAD, there was a significant difference
in the SMD between CAD and no-CAD groups (0.70 mm,
95% CI: 0.26-1.13, p = 0.002) in a random-effect pooled
analysis of these studies (fixed-effect model in the
Additional file 1: Figure S1). Statistically significant
heterogeneity was observed in the study results (p <
0.00001, I2 = 93%). There was no indication of publica-
tion bias with Egger’s test (p = 0.229, funnel plot shown
in Additional file 2: Figure S2). A sensitivity analysis, in
which one study was removed at a time, was performed
to evaluate the stability of the results. Results were
similar in all sensitivity analyses.
Subgroup analyses were performed in an attempt to
explore the possible causes of heterogeneity, according
to ethnicity, diagnostic tools for CAD, and measurement
tool of EAT thickness. In subgroup analysis according to
ethnicity shown in Table 3, the test for subgroup differ-
ences did not show a significant interaction. In contrast,
the test for subgroup differences showed a significant
interaction in the subgroup analysis according to diag-
nostic tools for CAD. In addition, the test for subgroup
differences showed a significant interaction according to
measurement tool of EAT thickness. In the subgroup of
echocardiography-based studies, the random-effects model
was used for the analysis, because the test for heterogeneity
was statistically significant (p < 0.00001; I2 = 94%). There
was a significant difference in the SMD between CAD and
no-CAD groups (0.98 mm, 95% CI: 0.43-1.53, p = 0.0005).dies to be included in the meta-analysis. EAT, epicardial
Table 1 Demographics of included studies in the association between location-specific EAT thickness at the right ventricular free wall and obstructive CAD





References Time No. of
patients






Chaowalit et al. [12] 2006 139 2.22 1.86 85 2.16 1.77 54 28.7 ± 5.5 Coronary angiography Echocardiography Non-Asian 20
Yun et al. [13] 2009 153 3.8 1.9 85 1.8 1.4 68 25.2 ± 3.1 Coronary angiography Echocardiography Asian 21
Eroglu et al. [14] 2009 150 7.3 1.2 80 4.68 1.13 70 28.9 ± 4.5 Coronary angiography Echocardiography Non-Asian 21
Wang et al. [11] 2010 224 4.3 1.8 140 4.1 2.0 84 26.1 ± 3.3 Coronary angiography CT Asian 21
Bastarrika et al. [20] 2010 45 8.57 2.08 23 7.69 2.68 22 29.1 ± 5.7 Coronary angiography CT Non-Asian 20
Mustelier et al. [16] 2011 250 6.6 2.8 185 4.7 2.3 65 27.4 ± 5.3 Coronary angiography Echocardiography Non-Asian 19
Shemirani et al. [17] 2012 292 5.4 1.9 171 4.4 1.8 121 NR Coronary angiography Echocardiography Non-Asian 19
Wu et al. [19] 2013 208 5.8 2.3 97 5.9 2.3 111 24.8 ± 3.3 Coronary CT angiography CT Asian 21
Kaya et al. [36] 2013 64 6.43 0.9 34 5.35 0.75 30 26.0 ± 3.0 Coronary angiography Echocardiography Non-Asian 19




















Table 2 Demographics of included studies in the association between location-specific EAT thickness at left AV groove and obstructive CAD





References Time No. of
patients






Wang et al. [11] 2010 224 13.2 3.1 140 11.3 2.5 84 26.1 ± 3.3 Coronary angiography CT Asian 21
Kim et al. [21] 2012 100 13 2.6 24 11.5 2.1 76 25.3 ± 3.2 Coronary MR angiography MRI Asian 21
Wu et al. [19] 2013 208 17.8 3.9 97 14.3 4.3 111 24.8 ± 3.3 Coronary CT angiography CT Asian 21




















Table 3 Subgroups analyses according to the ethnicity,
diagnostic tool, and measurement tool comparing
location-specific EAT thickness at the right ventricular
free wall in subjects of CAD and non-CAD groups
Subgroups Studies Subjects SMD (95% CI) p Value
Ethnicity
Asian 3 585 0.4 (-0.28 to 1.09) 0.36




8 1317 0.75 (0.34 to 1.16) 0.002
Coronary CT
angiography
1 208 -0.04 (-0.23 to 0.32)
Measurement tool
Echocardiography 6 1048 0.98 (0.43 to 1.53) 0.002
CT 3 477 0.06 (0.17 to 1.09)
p Value: test of interaction between subgroups. CAD, coronary artery disease;
SMD, standardized mean difference; CT, computed tomography.
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SMD between CAD and no-CAD groups (0.06 mm,
95% CI: -0.12-0.25, p = 0.50) in the subgroup of CT-
based studies, and greater homogeneity was also ob-
served within this subgroup shown in Figure 2 (p =
0.43; I2 = 0). Therefore, diagnostic tools for CAD and
measurement tool of EAT thickness were the potential
sources of heterogeneity between studies. In univariate
random effects meta-regression analysis, BMI was not
significantly associated with effect size shown in Figure 3
(95% CI: -0.24 -0.17, p = 0.59).Figure 2 Forest plot for SMD (random-effect model) in location-speci
and non-CAD group in the overall meta-analysis (including nine publ
measurement tool of EAT thickness (echocardiography or CT). SMD, standa
adipose tissue.Location-specific EAT thickness at the left AV groove and
obstructive CAD
Figure 4 shows the forest plot of the pooled results of the
SMD of the three studies in order to investigation the asso-
ciation between obstructive CAD and EAT thickness at the
left AV groove. In a fixed-effect pooled analysis, there was a
significant difference in the SMD between CAD and no-
CAD groups (0.74 mm, 95% CI: 0.55-0.92, p < 0.00001),
and low heterogeneity among the three studies shown in
Figure 4 (p = 0.61, I2 = 0%). Overall, location-specific EAT
thickness at the left AV groove was significantly thicker in
the CAD group than the no-CAD group. Publication bias
was not assessed because of limited studies.
Discussion
The role of location-specific EAT thickness at the right
ventricular free wall in obstructive CAD
With regard to the association between the location-
specific EAT thickness at the right ventricular free wall
and obstructive CAD, the overall results of the meta-
analysis in nine studies show a statistically significantly
increase in EAT thickness at the right ventricular free
wall in the CAD group than in the no-CAD group.
It should be clear that only the result of echocardiography-
based studies (six studies) showed a significant association
between CAD and the EAT thickness at right ventricular
free wall, and the result of all included CT-based studies
(three studies) showed a non-significant association. And
low between-study heterogeneity was also observed in the
CT-based studies (three studies) assessed at the right ven-
tricular free wall. However, extreme between-study het-
erogeneity was also observed in the overall meta-analysisfic EAT thickness at the right ventricular free wall between CAD
ished studies). In addition, subgroup analyses were assessed by the
rdized mean difference; CAD, coronary artery disease; EAT, epicardial
Figure 3 Meta-regression analysis between BMI and SMD of location-specific EAT thickness at right ventricular free wall. BMI, body
mass index; SMD, standardized mean difference; EAT, epicardial adipose tissue.
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studies). Therefore, all this evidence suggested that CT-
based measurement may potentially be a more reliable
tool than echocardiography-based measurement.
Regarding the association between location-specific
EAT thickness at the right ventricular free wall and ob-
structive CAD, subgroup and meta-regression analyses
for all covariates have been used to address the issues of
heterogeneity between studies. A recent meta-analysis of
worldwide study demonstrates a significant correlation be-
tween EAT and BMI, but shows a relationship between
EAT and metabolic syndrome independent of BMI [37].
These findings support the meta-regression analysis in our
study that revealed BMI was not considered a potential
source of heterogeneity between eight studies.
We think a possible explanation for the high heterogen-
eity between studies was that the difference in reliability
and reproducibility between the two tools (echocardiog-
raphy vs. CT) should be seriously concerned. In compari-
son with CT-based measurement, echocardiography is a
non-invasive imaging modality in EAT measurement thatFigure 4 Forest plot for SMD in location-specific EAT thickness at th
meta-analysis (including three published studies). SMD, standardize
adipose tissue; AV, atrioventricular.requires less cost and is less time-consuming. However, a
recent study has shown the poor reproducibility of echocar-
diographic EAT measurements assessed by intraclass cor-
relation coefficient, and low concordance observed between
CT and echocardiographic measurement [38]. One the
contrary, several studies have demonstrated high inter-
observer reliability and intraobserver reproducibility of
EAT thickness measured by CT [11,39,40]. Potential
measurement bias in the EAT measurement by echocar-
diography may contribute to the disparate results between
echocardiography-based and CT-based studies. And
recent longitudinal studies have also demonstrated non-
association between EAT thickness assessed by echocar-
diography and cardiac events or major adverse cardiac
events (MACE) [29,31], which also supports the negative
result by CT-based studies in the subgroup analysis. There-
fore, we suggest that the effect of location-specific EAT at
the right ventricular free wall on CAD is still uncertain.
However, future well-designed studies are warranted be-
cause of limited CT-based studies measuring location-
specific EAT thickness at the right ventricular free wall.e left AV groove between CAD and non-CAD groups in the
d mean difference; CAD, coronary artery disease; EAT, epicardial
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groove in obstructive CAD
With regard to the association between the location-
specific EAT thickness at the left AV groove and obstructive
CAD, the results from the current meta-analysis indicate
increased location-specific EAT thickness at the left AV
groove was associated with obstructive CAD assessed by
CT or MRI.
And high homogeneity between studies was observed,
despite diagnosis of CAD in different imaging modal-
ities, including coronary angiography, coronary CT angi-
ography and MR coronary angiography. Substantial
evidence has also supported the diagnostic accuracy of
coronary CT angiography and MR coronary angiography
in the evaluation of coronary arteries stenosis [41-43].
While there is no obvious explanation for this observa-
tion, uneven regional distribution of EAT around the
heart may provide clues. Recent studies also suggest that
location-specific EAT thickness at the left AV groove
may play a important causal role in cardiometabolic
disease through a possible mechanism described by
Wang et al. [11] whereby diffusion of EAT paracrine me-
tabolites through thin-walled coronary venous networks
into the coronary sinus is due to abundant coronary
venous sinus drainage networks in the left AV groove. In
addition, location-specific EAT thickness at the left AV
groove can be easily and reliably assessed in 2D-based
CT or MRI images available in routine clinical practice
for cardiovascular risk assessment [11,19,21]. Taken to-
gether, these findings may indicate that combined meas-
urement of EAT thickness in the left AV groove and
coronary calcium score provides more in-depth informa-
tion than conventional risk factor assessment in CAD
prediction [44]. Because of the limited number of studies
almost exclusively in Asian populations, future well-
designed cohort studies are warranted to investigate the
cause-effect relationship by CT or MRI.
Study strengths and limitations
It is our belief that the present study has demonstrated
certain advantages over the previous meta-analysis [45].
First, in contrast to previous meta-analysis by Xu et al.
[45] on this topic, we used explicit criteria to define
inclusion criteria. To investigate the association between
regional EAT thickness and CAD, we select the location-
specific EAT thickness at the right ventricular free wall or
left AV groove by echocardiography, CT or MRI rigorously.
However, the previous meta-analysis has used these data of
the “average” EAT thickness extracted from the study by
Wang et al. [11]. Second, the aims of the previous meta-
analysis and our study were both to investigate the relation-
ship between EAT thickness and CAD. We found one
included study in the previous meta-analysis that investi-
gated the relationship between regional EAT thickness anddescending thoracic aorta atherosclerosis [46], instead of all
included nine studies rigorously assessing obstructive CAD
in our study. Third, study quality was assessed using the
STROBE statement to ensure that all studies reach a level
of quality in this meta-analyses.
The current study had several potential limitations.
First, all ten included studies in the present meta-
analysis were case-control or cross-sectional studies
despite assessing study quality using the STROBE
statement, which has limitations in providing definite
information about the cause-and-effect relationship. In
addition, the best evidence comes primarily from
meta-analyses of randomized controlled trials. Second,
there are many confounding factors associated with
CAD, such as the Framingham risk score and CAC
score were not considered in this meta-analyses. How-
ever, we have investigated a number of factors to
explore between-study heterogeneity. The included
studies were different in diagnostic tools for CAD and
measurement tools of EAT, which may contribute to
the heterogeneity among the studies. Third, there are
limited studies in assessing the association between left
AVG EAT thickness and obstructive CAD despite recogni-
tion that homogeneity exists between studies, which may
lead to insufficient evidence to support the result.
Conclusion
In summary, our meta-analysis suggests that significantly
elevated location-specific EAT thickness at the left AV
groove is associated with obstructive CAD, and homo-
geneity influenced agreement between studies. Based on
the current evidence, the location-specific EAT thickness
at the left AV groove appears to play an influential role in
the prediction of obstructive CAD, especially in Asian pop-
ulations. In addition, adding EAT thickness at the left AV
groove on top of clinical CAD risk factors plus Agatston
score may provide further evidence in predicting CAD in
the population with suspicion of CAD [19,44]. Subsequent,
large, more definitive studies are needed to confirm these
findings and to establish if location-specific EAT thickness
at the left AV groove be used in clinical context.Additional files
Additional file 1: Figure S1. Forest plot for SMD (fixed-effect model)
in location-specific EAT thickness at the right ventricular free wall
between CAD and non-CAD groups in the overall meta-analysis (including
nine published studies). Moreover, subgroup analyses were assessed by the
measurement tool of EAT thickness (echocardiography or CT). SMD,
standardized mean difference; CAD, coronary artery disease; EAT,
epicardial adipose tissue.
Additional file 2: Figure S2. Funnel plot for potential publication bias
in the overall meta-analysis of the association between location-specific
EAT at the right ventricular free wall and obstructive CAD, including nine
studies. EAT, epicardial adipose tissue; CAD, coronary artery disease.
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